FARMACOCINÉTICA EXPERIMENTAL Y CLÍNICA
![Foto de FARMACOCINÉTICA EXPERIMENTAL Y CLÍNICA](/img/grupo.png)
![Foto de Dana–Farber Cancer Institute](/img/noimage_org.png)
Dana–Farber Cancer Institute
Boston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Dana–Farber Cancer Institute (2)
2023
-
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294
2015
-
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Nature Genetics, Vol. 47, Núm. 2, pp. 164-171